Ohio University
Athens, Ohio, 45701, United States
Location status: Recruiting
NCT Number: NCT06828926
Mild Cognitive Impairment (MCI) in older adults is linked to muscle loss (sarcopenia) and can lead to dementia, with pain further impacting cognitive and physical performance. Tai Chi, a mind-body exercise, is recommended for managing MCI as it supports cognitive function, mood, and physical health.
The investigators' first goal is to characterize the correlation of heart rate variability and cortical activity on cognitive function and the psychosocial correlates of pain interference and social isolation on cognitive function at baseline and post-intervention (8 weeks of Tai Chi). The second goal is to explain the role of sarcopenia and obesity in the relationship between pain interference and cognitive function. The investigators also want to examine the index of the predictive capacity regarding sarcopenia and obesity on cognitive function outcomes.
Interested in participating?
Request Info60 year and older
All sexes
Interventional
Not applicable
Athens, Ohio, 45701, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Tai Chi program content is based on the Harvard Medical School (HMS) Guide to Tai Chi, developed by clinical scientist Dr. Peter M. Wayne. Each participant will receive a workbook that describes the philosophy, evidence, and practice of Tai Chi, along with a video series for home practice that features the exercises from the HMS Guide to Tai Chi program. The in-person classes will be led by the PI and delivered weekly over 8 weeks, with 75-minute sessions. The in-person and video series will include an introduction to the principles of practice and tips on establishing and maintaining a practice, followed by a series of warm-up exercises, Tai Chi movements, and cool-down exercises. The Tin-person (and offer virtual live sessions for those who cannot attend in-person) over 8 weeks, accompanied by a workbook and video-recorded practices to promote self-management.
Time frame: From enrollment to the end of treatment at 8 weeks
Delis-Kaplan Executive Function System Stroop Color-Word Interference Test
Time frame: From enrollment to the end of treatment at 8 weeks
Repeatable Battery for the Assessment of Neuropsychological Status - Semantic Fluency Test
Time frame: From enrollment to the end of treatment at 8 weeks
Repeatable Battery for the Assessment of Neuropsychological Status Coding Test
Time frame: From enrollment to the end of treatment at 8 weeks
Patient Reported Outcome Measurement Information System (PROMIS) - Pain Interference Item Bank
Time frame: From enrollment to the end of treatment at 8 weeks
Patient Reported Outcome Measurement Information System (PROMIS) Social Isolation Item Bank
Time frame: From enrollment to the end of treatment at 8 weeks
Patient Reported Outcome Measurement Information System (PROMIS) Positive Affect Item Bank
Time frame: From enrollment to the end of treatment at 8 weeks
Patient Reported Outcome Measurement Information System (PROMIS) Meaning and Purpose Item bank
Time frame: From enrollment to the end of treatment at 8 weeks
Heart Rate Variability recorded while sitting for 5 minutes using a photoplethysmogram.
Time frame: From enrollment to the end of treatment at 8 weeks
Cortical activity will be recorded during a brief Tai Chi Practice before and after the 8-week Tai Chi intervention using a functional Near Infrared Spectroscopy system.
Time frame: From enrollment only
Montreal Cognitive Assessment used as a screening tool which measures short term memory, visuospatial abilities, executive functions, attention, concentration and working memory, and language orientation to time and place.
Time frame: From enrollment only
Body Mass Index (BMI) will be assessed to identify the moderating role of obesity on pain interference and executive function. Weight and height will be combined to report BMI in kg/m^2).
Time frame: From enrollment to the end of treatment at 8 weeks
(1) Hand Grip Strength using a JAMAR® dynamometer, adjusted to fit participants' hands as described elsewhere. A minimum of three trials with 60 seconds of rest between trials, and additional trials if the highest two values differ by more than 3 kg. Unit: Force in kilograms
The investigators will diagnose sarcopenia using the European Working Group's (EWGSOP2) revised consensus definition, which involves assessing two measures and current sarcopenia reference values: (i) hand grip strength via dynamometry and (ii) gait speed.
Time frame: From enrollment to the end of treatment at 8 weeks
(2) Usual Gait Speed over 4 meters to assess for gait speed. Unit: Seconds
The investigators will diagnose sarcopenia using the European Working Group's (EWGSOP2) revised consensus definition, which involves assessing two measures and current sarcopenia reference values: (i) hand grip strength via dynamometry and (ii) gait speed.
Time frame: From enrollment to the end of treatment at 8 weeks
(3) Six Minute Walk Test to assess for submaximal aerobic walking capacity. Unit: Meters
Time frame: From enrollment to the end of treatment at 8 weeks
(4) Four-Square Step Test to assess for dynamic balance that involves stepping over objects forward, sideways, and backward. Unit: Seconds
Time frame: From enrollment to the end of treatment at 8 weeks
(5) 5x Repeated Sit-to-Stand Test to assess lower extremity strength. Unit: Seconds
Time frame: From enrollment to the end of treatment at 8 weeks
(6) Stair Climb Power Test to assess lower extremity power. Unit: Seconds.
Contact information is provided by the study sponsor or research team.
Ohio University
Other
Project Gnosis: the Neural, Physical, and Psychosocial Processes and Health Outcomes of an 8-week Tai Chi Intervention in Older Adults with and Without Mild Cognitive Impairment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07583251
Cognition Disorders, Cognitive Dysfunction
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT06601933
Adherence Interventions, Behavior
Miami, Florida, United States
View Trial DetailsNCT07731334
Brain Diseases, Central Nervous System Diseases
Florence, FI, Italy
View Trial DetailsNCT07731191
Cognition Disorders, Cognitive Dysfunction
Brescia, BS, Italy
View Trial Details